Founded in 2020 and headquartered in Basel, Switzerland, Tenpoint Therapeutics is a British biotech firm focused on creating vision-restoring engineered cell-based therapeutics. Their innovative solutions aim to fundamentally transform the future for people with ocular diseases, offering a global impact.